To Severe Glabellar Lines
📧 Sign up to get email alerts when something new happens for To Severe Glabellar Lines.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: DWP450 for Treating Moderate to Severe Glabellar Lines [Phase 3]
Phase 3 trial update for DWP450 in treating moderate to severe glabellar lines has been completed.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines [Phase 3]
Phase 3 trial evaluating the efficacy and safety of QM1114-DP for moderate to severe glabellar lines has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: A Phase I/II Study of Recombinant Botulinum Toxin Type A for the Treatment of Moderate to Severe Glabellar Lines [Phase 1, Phase 2]
A combined Phase I/II trial evaluates recombinant Botulinum toxin type A for moderate to severe glabellar lines; the study status is complet…
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: Safety and Efficacy Study of ATGC-100 for the Treatment of Moderate to Severe Glabellar Lines in Adult Subjects [Phase 1, Phase 2]
Clinical trial update for ATGC-100 assessing safety and efficacy in treating moderate to severe glabellar lines (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines [Phase 3]
Phase 3 trial assessing efficacy and safety of Clostridium botulinum toxin type A for improving moderate to severe glabellar lines; results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.